Acute Kidney Injury
The treatment of Acute Kidney Injury (AKI) has changed dramatically with the change in the management of comorbidities associated with it, such as hypertension. With this change, the rationale applied in the approach taken to treat these changes has also evolved. The use of pharmacologic treatment of AKI has been tried with varying success rates due to inefficiencies in implementing approaches used in trials with animals in humans or the effectiveness of some of the tries (1). Some of the experimental therapies used today are hypoperfusion, and the preventative intervention has been the intravenous administration of isotonic saline (3). The lack has informed intravascular volume expansion using isotonic saline of sufficient evidence that colloids are more effective for this purpose and evidence that some colloids may result in AKI. The high cost of colloids also limits their use.
Action Mechanisms of the Drugs Used for Treatment
In some patients, colloids are used to reach resuscitation or to avoid excessive administration of fluids or among cirrhotic patients who have spontaneous peritonitis. Hypertonic or hypnotic crystalloids may be applied in ideal clinical scenarios where the selected crystalloid with altered tonicity is dictated by other goals rather than intravascular volume expansion, such as hyponatremia or hypernatremia. Isotonic solutions have 154 mmol/l Chloride and, when administered in large amounts, may result in obsolete or relative hyperchloremia (6). The buffered saline solution approximates the concentration of physiological chloride and causes a decline in the acid-base distribution. Once the intravascular volume is optimized, it is uncertain which vasopressor agent is the most suitable for managing shock since there are negligible differences between renal mortality and function (4). However, Vasopressin is gaining preference compared to norepinephrine since it enhances diuresis and increases blood pressure but is yet proven to enhance survival.
Appropriate vasoactive agents can improve kidney perfusion among patients in volume-restricted who have a vasomotor shock. The lack of protocolized therapies and standardized care has an array that limits the efficacy of using postoperative therapies. Insufficient management strategies, standardized hemodynamic, and tissue oxygenation targets to assess the efficacy of the protocolized therapies compared...
…20% mannitol before the vessel cramp during renal transplant served a preventative function (6). Further, it reduced post-transplant incidences of AKI.Further, its administration in rhabdomyolysis is beneficial since it stimulates osmotic diuresis and lowers the intercompartmental pressure in the affected limbs. However, the use of a low dosage of dopamine is recommended for patients who are diagnosed with Grade 1 AKI. The use of diuretics to prevent AKI Grade 1B should be avoided. However, they may be used to treat volume overload among AKI Grade 2C patients.
Dosages and Routes of Drugs Administration
For patients with a Grade 2 AKI, aminoglycosides should be used to treat infections unless they are not suitable, less nephrotoxic, therapeutic alternatives are available. They should be administered once a day, and therapeutic drug monitoring should be exercised (6). The peak drug level should be maintained at 10-fold more than the minimum inhibitory concentration involving the infecting microorganism in extended-dose or single-dose treatment strategies. Among critically ill patients, a single dose of theophylline may be administered in neonates with severe perinatal asphyxia that…
References
1. Basile DP, Anderson MD, Sutton TA. Pathophysiology of acute kidney injury. Comprehensive Physiology (2012).
2. Chen TK, Parikh CR. Management of presumed acute kidney injury during hypertensive therapy: Stay calm and carry on? American Journal of Nephrology 51: 108–115, 2020.
3. Jo SK, Rosner MH, Okusa MD. Pharmacologic treatment of acute kidney injury: Why drugs haven’t worked and what is on the Horizon. Clinical Journal of the American Society of Nephrology 2: 356–365, 2007.
Acute kidney diseases can be severe in the short-term but once treated, the kidney functions return to normal (National Institutes of Health). Hemolytic uremic syndrome and Nephrotic syndrome are acute kidney diseases affecting children. Most acute kidney diseases are caused by trauma, injury, or poisoning. Chronic conditions include deformed kidneys that are due to birth defects, the hereditary disease polycystic kidney disease (PKD), Glomerular diseases, and Systemic diseases (National Institutes
Polycystic kidney disease (PKD) is an inherited disorder distinguished by the growth of lots of cysts in the kidneys ("Polycystic Kidney Disease" 1). In the majority of cases, this genetic disease is passed down through families as an autosomal dominant trait. If a parent is the carrier of the gene, there is a fifty percent chance for the children to develop the disorder ("Polycystic Kidney Disease"). The kidneys are two organs.
Chronic Kidney Disease Over the last several years, the issue of chronic kidney disease has been increasingly brought to the forefront. This is because when someone becomes older, the more likely they will develop this condition. According to the Center for Disease Control (CDC) and the National Kidney Foundation, once someone reaches above the age of 50, there is a 50% of them becoming susceptible to it. As they increase in
, Sweet, Starkey, Shekelle, 2013, p. 835). Depending on whether the patient is in early-stage vs. late-stage prognosis, the patient will be offered different treatments and approaches to managing the disease and its effects. According to Qaseem et al., Stage 1 -- 3 CKD is treated in a variety of methods; different types of medicine, diets, exercise, and other treatments and approaches are all available, some with better results than others
Acute Kidney DiseaseAcute kidney disease also known as acute renal failure is a disease which happens to be associated with high mortality and morbidity. The said disease is caused by ischemia (1). Previous studies have revealed the association between ischemia and loss in NPK cells and cadherin cleavage owing to matrix metalloproteinase (MMP). One such study was conducted to identify MMP that was needed for N-cadherin loss and N-cadherin cleavage.
Chronic Kidney Disease CKD, or Chronic Kidney Disease, refers to the impairment a person suffers in his/her kidneys, which may result in their reduced function, as time progresses. Chronic Kidney Disease is used as a replacement for previously held terms, such as the Chronic Renal Failure and Chronic Renal Insufficiency by the paediatric nephrology specialists. These terms were formerly used to describe the reduction of renal functions, whether to a large
Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.
Get Started Now